| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8443898 | European Journal of Cancer | 2013 | 7 Pages |
Abstract
This is the first randomised trial on maintenance therapy in metastatic pancreatic adenocarcinoma. The primary end-point was fulfilled and 2y overall survival was remarkably high, suggesting that maintenance sunitinib is promising and should be further explored in this patient population.
Keywords
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Michele Reni, Stefano Cereda, Michele Milella, Anna Novarino, Alessandro Passardi, Andrea Mambrini, Giuseppe Di Lucca, Giuseppe Aprile, Carmen Belli, Marco Danova, Francesca Bergamo, Enrico Franceschi, Clara Fugazza, Domenica Ceraulo, Eugenio Villa,